Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Guardian Pharmacy Services (GRDN) Long-Term Debt Repayments (2023 - 2024)

Guardian Pharmacy Services recorded quarterly Long-Term Debt Repayments of $34.2 million in Q4 2024, up 2390.91% quarter-over-quarter from $1.4 million in Q3 2024, and up 3325.0% year-over-year from $1.0 million in Q1 2024.

Guardian Pharmacy Services' Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at $34.2 million for Q4 2024.

  • In Q4 2024, Long-Term Debt Repayments rose 3325.0% year-over-year to $34.2 million; the TTM figure through Dec 2025 stood at $37.0 million (down 2.63% YoY), while the FY2025 annual figure was $497000.0, down 98.69% from the prior year.
  • Long-Term Debt Repayments came in at $34.2 million for Q4 2024 at Guardian Pharmacy Services, up from $1.4 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $34.2 million in Q4 2024 to a low of $1.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 58.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 33.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 917.09 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 330.00 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 1.04 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 44.73 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 44.28 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Guardian Pharmacy Services 2.45 Mn -50.91 Mn 76.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 34.25 Mn
Dec 31, 2024 34.25 Mn
Sep 30, 2024 1.38 Mn
Sep 30, 2024 1.38 Mn
Jun 30, 2024 1.38 Mn
Jun 30, 2024 1.38 Mn
Mar 31, 2024 1.00 Mn
Mar 31, 2024 1.00 Mn
Dec 31, 2023 1.00 Mn
Dec 31, 2023 1.00 Mn